R&D SYSTEMS 产品目录列表 2022年 有少量现货 价格优惠详细信息相关产品
| 产品编号 | 产品描述 | 规格/包装 | 品牌 |
| 1135-RA-050 | Recombinant Mouse Rae-1 epsilon/Fc Chimera, CF (50 UG) | 50 UG | R&D SYSTEMS |
| 1136-RA-050 | Recombinant Mouse Rae-1 gamma/Fc Chimera, CF (50 UG) | 50 UG | R&D SYSTEMS |
| 1137-SL-050 | Recombinant Human Siglec-3/CD33/Fc Chimera, CF (50 UG) | 50 UG | R&D SYSTEMS |
| 1138-SL-050 | Recombinant Human Siglec-7/Fc Chimera, CF (50 UG) | 50 UG | R&D SYSTEMS |
| 1139-SL-050 | Recombinant Human Siglec-9/Fc Chimera, CF (50 UG) | 50 UG | R&D SYSTEMS |
| 113-BP-100 | Recombinant Human BMP-3 (100 UG) | 100 UG | R&D SYSTEMS |
| 113-BP-100/CF | Recombinant Human BMP-3, CF (100 UG) | 100 UG | R&D SYSTEMS |
| 1141-PI-010 | Recombinant Mouse HAI-1, CF (10 UG) | 10 UG | R&D SYSTEMS |
| 11450-1 | Recombinant Human IFN-kappa, CF | 50 µg | R&D SYSTEMS |
| 1145-RG-050 | Recombinant Human RAGE/Fc Chimera, CF (50 UG) | 50 UG | R&D SYSTEMS |
| 1146-S6-025 | Recombinant Human Semaphorin 6A/Fc Chimera, CF (25 UG) | 25 UG | R&D SYSTEMS |
| 1150-ML-020 | Recombinant Mouse IL-2 (Cys 141 Ser) (20 UG) | 20 UG | R&D SYSTEMS |
| 1150-ML-020/CF | Recombinant Mouse IL-2 (Cys 141 Ser), CF (20 UG) | 20 UG | R&D SYSTEMS |
| 1151-CL-025 | Recombinant Human CLF-1/CLC Complex (25 UG) | 25 UG | R&D SYSTEMS |
| 1151-CL-025/CF | Recombinant Human CLF-1/CLC Complex, CF (25 UG) | 25 UG | R&D SYSTEMS |
| 1152-GA-050 | Recombinant Human Galectin-1 (50 UG) | 50 UG | R&D SYSTEMS |
| 1152-GA-050/CF | Recombinant Human Galectin-1, CF (50 UG) | 50 UG | R&D SYSTEMS |
| 1153-GA-050 | Recombinant Human Galectin-2 (50 UG) | 50 UG | R&D SYSTEMS |
| 1153-GA-050/CF | Recombinant Human Galectin-2, CF (50 UG) | 50 UG | R&D SYSTEMS |
| 1154-GA-050 | Recombinant Human Galectin-3 (50 UG) | 50 UG | R&D SYSTEMS |
| 1154-GA-050/CF | Recombinant Human Galectin-3, CF (50 UG) | 50 UG | R&D SYSTEMS |
| 1155-H6-050 | Recombinant Mouse H60/Fc Chimera, CF (50 UG) | 50 UG | R&D SYSTEMS |
| 1156-NG-100 | Recombinant Mouse beta-NGF (100 UG) | 100 UG | R&D SYSTEMS |
| 1156-NG-100/CF | Recombinant Mouse beta-NGF, CF (100 UG) | 100 UG | R&D SYSTEMS |
| 1157-NR-050 | Recombinant Mouse NGF R/TNFRSF16/Fc Chimera, CF (50 UG) | 50 UG | R&D SYSTEMS |
| 1158-RA-050 | Recombinant Mouse Rae-1 alpha/Fc Chimera, CF (50 UG) | 50 UG | R&D SYSTEMS |
| 1159-SB-025 | Recombinant Human PDGF-DD (25 UG) | 25 UG | R&D SYSTEMS |
| 1159-SB-025/CF | Recombinant Human PDGF-DD, CF (25 UG) | 25 UG | R&D SYSTEMS |
| 1160-A1-050 | Recombinant Human Bcl-2 related protein A1 (aa 1-152), CF (50 UG) | 50 UG | R&D SYSTEMS |
| 1161-LV-100 | Recombinant Human Livin alpha/KIAP, CF (100 UG) | 100 UG | R&D SYSTEMS |
| 1162-BR-050 | Recombinant Human BAFF R/TNFRSF13C/Fc Chimera, CF (50 UG) | 50 UG | R&D SYSTEMS |
| 1163-CL-025 | Recombinant Mouse CD40 Ligand/TNFSF5 (25 UG) | 25 UG | R&D SYSTEMS |
| 1163-CL-025/CF | Recombinant Mouse CD40 Ligand/TNFSF5, CF (25 UG) | 25 UG | R&D SYSTEMS |
| 1164-CX-025 | Recombinant Human CXCL16 (Histidine-tagged) (25 UG) | 25 UG | R&D SYSTEMS |
| 1164-CX-025/CF | Recombinant Human CXCL16 (Histidine-tagged), CF (25 UG) | 25 UG | R&D SYSTEMS |
| 1165-CX-025 | Recombinant Mouse CXCL16 (Histidine-tagged) (25 UG) | 25 UG | R&D SYSTEMS |
| 1165-CX-025/CF | Recombinant Mouse CXCL16 (Histidine-tagged), CF (25 UG) | 25 UG | R&D SYSTEMS |
| 1166-NG-025 | Recombinant Mouse Netrin-G1a (25 UG) | 25 UG | R&D SYSTEMS |
| 1166-NG-025/CF | Recombinant Mouse Netrin-G1a, CF (25 UG) | 25 UG | R&D SYSTEMS |
| 1167-PR-050 | Recombinant Human Prolactin R/Fc Chimera, CF (50 UG) | 50 UG | R&D SYSTEMS |
| 1168-CR-050 | Recombinant Human Ret (Histidine-tagged) (50 UG) | 50 UG | R&D SYSTEMS |
| 1168-CR-050/CF | Recombinant Human Ret (Histidine-tagged), CF (50 UG) | 50 UG | R&D SYSTEMS |
| 1169-FR-025 | Recombinant Mouse sFRP-2 (25 UG) | 25 UG | R&D SYSTEMS |
| 1169-FR-025/CF | Recombinant Mouse sFRP-2, CF (25 UG) | 25 UG | R&D SYSTEMS |
| 1172-AL-050 | Recombinant Mouse ALCAM/Fc Chimera, CF (50 UG) | 50 UG | R&D SYSTEMS |
| 1173-M5-050 | Recombinant Mouse ICAM-5/Fc Chimera, CF (50 UG) | 50 UG | R&D SYSTEMS |
| 1176-IR-050 | Recombinant Human IL-20 R alpha/Fc Chimera, CF (50 UG) | 50 UG | R&D SYSTEMS |
| 1179-RG-050 | Recombinant Mouse RAGE/Fc Chimera, CF (50 UG) | 50 UG | R&D SYSTEMS |
| 117-VL-025 | Recombinant Viral HCMV IL-10 (25 UG) | 25 UG | R&D SYSTEMS |
| 117-VL-025/CF | Recombinant Viral HCMV IL-10, CF (25 UG) | 25 UG | R&D SYSTEMS |
| 1180-SE-010 | Recombinant Human DPPIV/CD26, CF (10 UG) | 10 UG | R&D SYSTEMS |
| 1182-ZN-010 | Recombinant Human Neprilysin, CF (10 UG) | 10 UG | R&D SYSTEMS |
| 1183-CY-010 | Recombinant Human Cathepsin S, CF (10 UG) | 10 UG | R&D SYSTEMS |
| 1184-PI-050 | Recombinant Human Fetuin A/AHSG, CF (50 UG) | 50 UG | R&D SYSTEMS |
| 1187-TR-025 | Recombinant Mouse TREM-1/Fc Chimera, CF (25 UG) | 25 UG | R&D SYSTEMS |
| 1189-J3-050 | Recombinant Human JAM-C/Fc Chimera, CF (50 UG) | 50 UG | R&D SYSTEMS |
| 118-AP-100 | Recombinant Human IL-18 R beta/IL-1 R7/Fc Chimera, CF (100 UG) | 100 UG | R&D SYSTEMS |
| 1190-NT-050 | Recombinant Rat Notch-2/Fc Chimera, CF (50 UG) | 50 UG | R&D SYSTEMS |
| 1195-EP-025 | Recombinant Human Epiregulin (25 UG) | 25 UG | R&D SYSTEMS |
| 1195-EP-025/CF | Recombinant Human Epiregulin, CF (25 UG) | 25 UG | R&D SYSTEMS |
| 1196-PI-010 | Recombinant Human Cystatin C, CF (10 UG) | 10 UG | R&D SYSTEMS |
| 11976-1 | Thymosin alpha 1, CF | 500 µg | R&D SYSTEMS |
| 1197-GA-050 | Recombinant Mouse Galectin-3 (50 UG) | 50 UG | R&D SYSTEMS |
| 1197-GA-050/CF | Recombinant Mouse Galectin-3, CF (50 UG) | 50 UG | R&D SYSTEMS |
| 1198-RA-050 | Recombinant Mouse Rae-1 beta/Fc Chimera, CF (50 UG) | 50 UG | R&D SYSTEMS |
| 1199-TW-050 | Recombinant Human TWEAK R/TNFRSF12/Fc Chimera, CF (50 UG) | 50 UG | R&D SYSTEMS |
| 119-BP-100 | Recombinant Human IL-18 BPa/Fc Chimera, CF (100 UG) | 100 UG | R&D SYSTEMS |
| 1200-SE-010 | Recombinant Mouse HGF Activator, CF (10 UG) | 10 UG | R&D SYSTEMS |
| 1201-PI-010 | Recombinant Human Cystatin SA, CF (10 UG) | 10 UG | R&D SYSTEMS |
| 1202-PI-010 | Recombinant Human Cystatin D, CF (10 UG) | 10 UG | R&D SYSTEMS |
| 1204-ML-025 | Recombinant Mouse IL-20 (25 UG) | 25 UG | R&D SYSTEMS |
| 1204-ML-025/CF | Recombinant Mouse IL-20, CF (25 UG) | 25 UG | R&D SYSTEMS |
| 1206-F3-025 | Recombinant Human FGF-3 (25 UG) | 25 UG | R&D SYSTEMS |
| 1206-F3-025/CF | Recombinant Human FGF-3, CF (25 UG) | 25 UG | R&D SYSTEMS |
| 1207-BR-050 | Recombinant Human IL-17B R/Fc Chimera, CF (50 UG) | 50 UG | R&D SYSTEMS |
| 1208-NG-050 | Recombinant Human Nogo Receptor/Fc Chimera, CF (50 UG) | 50 UG | R&D SYSTEMS |
| 1209-EV-025 | Recombinant Human EG-VEGF/PK1 (25 UG) | 25 UG | R&D SYSTEMS |
| 1209-EV-025/CF | Recombinant Human EG-VEGF/PK1, CF (25 UG) | 25 UG | R&D SYSTEMS |
| 120-HD-001 | Human PDGF, CF (1 UG) | 1 UG | R&D SYSTEMS |
| 120-HD-005 | Human PDGF, CF (5 UG) | 5 UG | R&D SYSTEMS |
| 12105-1 | Recombinant Mouse IFN-alpha 1 | 100000 U | R&D SYSTEMS |
| 1210-GR-050 | Recombinant Human Growth Hormone R (GHR)/Fc Chimera, CF (50 UG) | 50 UG | R&D SYSTEMS |
| 12110-1 | Recombinant Mouse IFN-alpha 4 | 100000 U | R&D SYSTEMS |
| 1211-GR-050 | Recombinant Rat Growth Hormone R (GHR)/Fc Chimera, CF (50 UG) | 50 UG | R&D SYSTEMS |
| 12125-1 | Recombinant Mouse IFN-alpha 11 | 100000 U | R&D SYSTEMS |
| 1212-FG-025 | Recombinant Human FGF-16 (25 UG) | 25 UG | R&D SYSTEMS |
| 1212-FG-025/CF | Recombinant Human FGF-16, CF (25 UG) | 25 UG | R&D SYSTEMS |
| 12130-1 | Recombinant Mouse IFN-alpha 13 | 100000 U | R&D SYSTEMS |
| 1213-J3-050 | Recombinant Mouse JAM-C/Fc Chimera, CF (50 UG) | 50 UG | R&D SYSTEMS |
| 1214-B7-050 | Recombinant Rat B7-1/CD80/Fc Chimera, CF (50 UG) | 50 UG | R&D SYSTEMS |
| 1215-CD-050 | Recombinant Mouse CD40/TNFRSF5/Fc Chimera, CF (50 UG) | 50 UG | R&D SYSTEMS |
| 1220-PG-025 | Recombinant Human Aggrecan G1-IGD-G2 Domains, CF (25 UG) | 25 UG | R&D SYSTEMS |
| 1224-PL-100 | Recombinant Human PD-L2/Fc Chimera, CF (100 UG) | 100 UG | R&D SYSTEMS |
| 1227-GA-050 | Recombinant Human Galectin-4 (50 UG) | 50 UG | R&D SYSTEMS |
| 1227-GA-050/CF | Recombinant Human Galectin-4, CF (50 UG) | 50 UG | R&D SYSTEMS |
| 122-BP-100 | Recombinant Mouse IL-18BPd/Fc Chimera, CF (100 UG) | 100 UG | R&D SYSTEMS |
| 1234-IL-025 | Recombinant Human IL-17C (25 UG) | 25 UG | R&D SYSTEMS |
| 1234-IL-025/CF | Recombinant Human IL-17C, CF (25 UG) | 25 UG | R&D SYSTEMS |
| 1236-OX-025 | Recombinant Mouse OX40 Ligand/TNFSF4 (25 UG) | 25 UG | R&D SYSTEMS |
| 1236-OX-025/CF | Recombinant Mouse OX40 Ligand/TNFSF4, CF (25 UG) | 25 UG | R&D SYSTEMS |
| 1237-TW-025 | Recombinant Mouse TWEAK/TNFSF12 (25 UG) | 25 UG | R&D SYSTEMS |
| 1237-TW-025/CF | Recombinant Mouse TWEAK/TNFSF12, CF (25 UG) | 25 UG | R&D SYSTEMS |
| 1238-PI-010 | Recombinant Mouse Cystatin C, CF (10 UG) | 10 UG | R&D SYSTEMS |
| 1239-PI-010 | Recombinant Mouse Serpin F2/alpha 2-Antiplasmin, CF (10 UG) | 10 UG | R&D SYSTEMS |
| 123-FE-050 | Recombinant Human CD23/Fc epsilon RII, CF (50 UG) | 50 UG | R&D SYSTEMS |
| 1245-GA-050 | Recombinant Mouse Galectin-1 (50 UG) | 50 UG | R&D SYSTEMS |
| 1245-GA-050/CF | Recombinant Mouse Galectin-1, CF (50 UG) | 50 UG | R&D SYSTEMS |
| 1246-4L-025 | Recombinant Mouse 4-1BB Ligand/TNFSF9 (25 UG) | 25 UG | R&D SYSTEMS |
| 1246-4L-025/CF | Recombinant Mouse 4-1BB Ligand/TNFSF9, CF (25 UG) | 25 UG | R&D SYSTEMS |
| 1247-ZV-010 | Recombinant Zebrafish VEGF 165 (10 UG) | 10 UG | R&D SYSTEMS |
| 1247-ZV-010/CF | Recombinant Zebrafish VEGF 165, CF (10 UG) | 10 UG | R&D SYSTEMS |
| 1248-IB-025 | Recombinant Human IL-17B (25 UG) | 25 UG | R&D SYSTEMS |
| 1248-IB-025/CF | Recombinant Human IL-17B, CF (25 UG) | 25 UG | R&D SYSTEMS |
| 1250-S3-025 | Recombinant Human Semaphorin 3A/Fc Chimera, CF (25 UG) | 25 UG | R&D SYSTEMS |
| 1254-N4-025 | Recombinant Human Netrin-4 (25 UG) | 25 UG | R&D SYSTEMS |
| 1254-N4-025/CF | Recombinant Human Netrin-4, CF (25 UG) | 25 UG | R&D SYSTEMS |
| 1255-F3-025 | Recombinant Mouse FLRG (25 UG) | 25 UG | R&D SYSTEMS |
| 1255-F3-025/CF | Recombinant Mouse FLRG, CF (25 UG) | 25 UG | R&D SYSTEMS |
| 1256-OX-050 | Recombinant Mouse OX40/TNFRSF4/Fc Chimera, CF (50 UG) | 50 UG | R&D SYSTEMS |
| 1257-FC-050 | Recombinant Human Fc gamma RIA/CD64, CF (50 UG) | 50 UG | R&D SYSTEMS |
| 1258-IL-025 | Recombinant Human IL-17E (25 UG) | 25 UG | R&D SYSTEMS |
| 1258-IL-025/CF | Recombinant Human IL-17E, CF (25 UG) | 25 UG | R&D SYSTEMS |
| 125-PD-005 | Porcine PDGF, CF (5 UG) | 5 UG | R&D SYSTEMS |
| 1264-FR-050 | Recombinant Human FGF R3 (IIIb)/Fc Chimera, CF (50 UG) | 50 UG | R&D SYSTEMS |
| 1265-PI-010 | Recombinant Mouse Serpin D1/Heparin Cofactor II, CF (10 UG) | 10 UG | R&D SYSTEMS |
| 1266-PI-010 | Recombinant Human Serpin A5, CF (10 UG) | 10 UG | R&D SYSTEMS |
| 1267-PI-010 | Recombinant Human Serpin C1/Antithrombin-III, CF (10 UG) | 10 UG | R&D SYSTEMS |
| 1268-PI-010 | Recombinant Human Serpin A1, CF (10 UG) | 10 UG | R&D SYSTEMS |
| 1269-DK-010 | Recombinant Human Dkk-4 (10 UG) | 10 UG | R&D SYSTEMS |
| 1269-DK-010/CF | Recombinant Human Dkk-4, CF (10 UG) | 10 UG | R&D SYSTEMS |
| 126-FL-010 | Recombinant Human Fas Ligand/TNFSF6 (10 UG) | 10 UG | R&D SYSTEMS |
| 126-FL-010/CF | Recombinant Human Fas Ligand/TNFSF6, CF (10 UG) | 10 UG | R&D SYSTEMS |
| 1274-PI-100 | Recombinant Human SLPI, CF (100 UG) | 100 UG | R&D SYSTEMS |
| 1275-IL-025 | Recombinant Human IL-1F5/FIL1 delta (25 UG) | 25 UG | R&D SYSTEMS |
| 1275-IL-025/CF | Recombinant Human IL-1F5/FIL1 delta, CF (25 UG) | 25 UG | R&D SYSTEMS |
| 1278-TR-050 | Recombinant Human TREM-1/Fc Chimera, CF (50 UG) | 50 UG | R&D SYSTEMS |
| 127-N2-025 | Recombinant Chicken Netrin-2 (25 UG) | 25 UG | R&D SYSTEMS |
| 127-N2-025/CF | Recombinant Chicken Netrin-2, CF (25 UG) | 25 UG | R&D SYSTEMS |
| 1280-ER-050 | Recombinant Mouse EGF R/Fc Chimera, CF (50 UG) | 50 UG | R&D SYSTEMS |
| 1284-PI-010 | Recombinant Mouse Cystatin E/M, CF (10 UG) | 10 UG | R&D SYSTEMS |
| 1285-PI-010 | Recombinant Human Cystatin SN, CF (10 UG) | 10 UG | R&D SYSTEMS |
| 1286-PI-010 | Recombinant Human Cystatin E/M, CF (10 UG) | 10 UG | R&D SYSTEMS |
| 1287-PI-010 | Recombinant Mouse Serpin C1/Antithrombin-III, CF (10 UG) | 10 UG | R&D SYSTEMS |
| 1288-F3-025 | Recombinant Human FLRG (25 UG) | 25 UG | R&D SYSTEMS |
| 1288-F3-025/CF | Recombinant Human FLRG, CF (25 UG) | 25 UG | R&D SYSTEMS |
| 128-N1-025 | Recombinant Chicken Netrin-1 (25 UG) | 25 UG | R&D SYSTEMS |
| 128-N1-025/CF | Recombinant Chicken Netrin-1, CF (25 UG) | 25 UG | R&D SYSTEMS |
| 1290-IL-010 | Recombinant Human IL-23 (10 UG) | 10 UG | R&D SYSTEMS |
| 1290-IL-010/CF | Recombinant Human IL-23, CF (10 UG) | 10 UG | R&D SYSTEMS |
| 1294-AS-010 | Recombinant Human Cathepsin E, CF (10 UG) | 10 UG | R&D SYSTEMS |
| 1295-PI-010 | Recombinant Human Serpin A3, CF (10 UG) | 10 UG | R&D SYSTEMS |
| 1296-PI-010 | Recombinant Human Cystatin S, CF (10 UG) | 10 UG | R&D SYSTEMS |
| 1297-NE-025 | Recombinant Human Neurturin (25 UG) | 25 UG | R&D SYSTEMS |
| 1297-NE-025/CF | Recombinant Human Neurturin, CF (25 UG) | 25 UG | R&D SYSTEMS |
| 1298-UL-050 | Recombinant Human ULBP-2/Fc Chimera, CF (50 UG) | 50 UG | R&D SYSTEMS |
| 1299-NK-050 | Recombinant Human NKG2D/Fc Chimera, CF (50 UG) | 50 UG | R&D SYSTEMS |
| 1300-MA-050 | Recombinant Human MICA/Fc Chimera, CF (50 UG) | 50 UG | R&D SYSTEMS |
| 1304-GA-050 | Recombinant Mouse Galectin-7 (50 UG) | 50 UG | R&D SYSTEMS |
| 1304-GA-050/CF | Recombinant Mouse Galectin-7, CF (50 UG) | 50 UG | R&D SYSTEMS |
| 1305-GA-050 | Recombinant Human Galectin-8 (50 UG) | 50 UG | R&D SYSTEMS |
| 1305-GA-050/CF | Recombinant Human Galectin-8, CF (50 UG) | 50 UG | R&D SYSTEMS |
| 1306-RE-010 | Recombinant Rat Erythropoietin (10 UG) | 10 UG | R&D SYSTEMS |
| 1306-RE-010/CF | Recombinant Rat Erythropoietin, CF (10 UG) | 10 UG | R&D SYSTEMS |
| 1307-FZ-050 | Recombinant Mouse Frizzled-2/Fc Chimera, CF (50 UG) | 50 UG | R&D SYSTEMS |
| 1308-NT-050 | Recombinant Mouse Notch-3/Fc Chimera, CF (50 UG) | 50 UG | R&D SYSTEMS |
| 1309-PR-050 | Recombinant Mouse Prolactin R/Fc Chimera, CF (50 UG) | 50 UG | R&D SYSTEMS |
| 130-MD-050 | Recombinant Mouse MD-1 (50 UG) | 50 UG | R&D SYSTEMS |
| 130-MD-050/CF | Recombinant Mouse MD-1, CF (50 UG) | 50 UG | R&D SYSTEMS |
| 1310-SE-010 | Recombinant Human u-Plasminogen Activator/Urokinase, CF (10 UG) | 10 UG | R&D SYSTEMS |
| 1314-SH-025 | Recombinant Human Sonic Hedgehog, N-Terminus (Shh-N) (25 UG) | 25 UG | R&D SYSTEMS |
| 1314-SH-025/CF | Recombinant Human Sonic Hedgehog, N-Terminus (Shh-N), CF (25 UG) | 25 UG | R&D SYSTEMS |
| 1315-ND-025 | Recombinant Mouse Nodal (25 UG) | 25 UG | R&D SYSTEMS |
| 1315-ND-025/CF | Recombinant Mouse Nodal, CF (25 UG) | 25 UG | R&D SYSTEMS |
| 1316-RL-010 | Recombinant Rat IL-22 (10 UG) | 10 UG | R&D SYSTEMS |
| 1316-RL-010/CF | Recombinant Rat IL-22, CF (10 UG) | 10 UG | R&D SYSTEMS |
| 1317-TR-050 | Recombinant Mouse Thrombopoietin R/Fc Chimera, CF (50 UG) | 50 UG | R&D SYSTEMS |
| 1318-RL-010 | Recombinant Rhesus Macaque IL-1 beta/IL-1F2 (10 UG) | 10 UG | R&D SYSTEMS |
| 1318-RL-010/CF | Recombinant Rhesus Macaque IL-1 beta/IL-1F2, CF (10 UG) | 10 UG | R&D SYSTEMS |
| 1319-TL-010 | Recombinant Human TL1A/TNFSF15 (10 UG) | 10 UG | R&D SYSTEMS |
| 1319-TL-010/CF | Recombinant Human TL1A/TNFSF15, CF (10 UG) | 10 UG | R&D SYSTEMS |
| 131-M1-025 | Recombinant Human CCL23/MPIF-1 (aa 46-120) (25 UG) | 25 UG | R&D SYSTEMS |
| 131-M1-025/CF | Recombinant Human CCL23/MPIF-1 (aa 46-120), CF (25 UG) | 25 UG | R&D SYSTEMS |
| 1320-EN-025 | Recombinant Mouse Endoglin/CD105/Fc Chimera, CF (25 UG) | 25 UG | R&D SYSTEMS |
| 1324-WN-002 | Recombinant Mouse Wnt-3a (2 UG) | 2 UG | R&D SYSTEMS |
| 1325-BL-050 | Recombinant Human BIM (Long Form), CF (50 UG) | 50 UG | R&D SYSTEMS |
| 1328-PI-050 | Recombinant E. coli Ecotin, CF (50 UG) | 50 UG | R&D SYSTEMS |
| 132-FA-025 | Bovine FGF acidic (25 UG) | 25 UG | R&D SYSTEMS |
| 132-FA-025/CF | Bovine FGF acidic, CF (25 UG) | 25 UG | R&D SYSTEMS |
| 1330-CD-050 | Recombinant Human Fc gamma RIIA/CD32a (50 UG) | 50 UG | R&D SYSTEMS |
| 1330-CD-050/CF | Recombinant Human Fc gamma RIIA/CD32a, CF (50 UG) | 50 UG | R&D SYSTEMS |
| 1334-B7-025 | Recombinant Human IGFBP-rp1/IGFBP-7, CF (25 UG) | 25 UG | R&D SYSTEMS |
| 1335-IL-025 | Recombinant Human IL-17F (25 UG) | 25 UG | R&D SYSTEMS |
| 1335-IL-025/CF | Recombinant Human IL-17F, CF (25 UG) | 25 UG | R&D SYSTEMS |
| 1335-INS-025 | Recombinant Human IL-17F (NSO-expressed) (25 UG) | 25 UG | R&D SYSTEMS |
| 1335-INS-025/CF | Recombinant Human IL-17F (NSO-expressed), CF (25 UG) | 25 UG | R&D SYSTEMS |
| 1339-GA-050 | Recombinant Human Galectin-7 (50 UG) | 50 UG | R&D SYSTEMS |
| 1339-GA-050/CF | Recombinant Human Galectin-7, CF (50 UG) | 50 UG | R&D SYSTEMS |
| 133-FB-025 | Bovine FGF basic (25 UG) | 25 UG | R&D SYSTEMS |
| 133-FB-025/CF | Bovine FGF basic, CF (25 UG) | 25 UG | R&D SYSTEMS |
| 1340-B2-050 | Recombinant Rat B7-2/CD86/Fc Chimera, CF (50 UG) | 50 UG | R&D SYSTEMS |
| 1341-WF-050 | Recombinant Human WIF-1 (50 UG) | 50 UG | R&D SYSTEMS |
| 1341-WF-050/CF | Recombinant Human WIF-1, CF (50 UG) | 50 UG | R&D SYSTEMS |
| 1344-SE-010 | Recombinant Human Kallikrein 3/PSA, CF (10 UG) | 10 UG | R&D SYSTEMS |
| 1346-SE-010 | Recombinant Mouse Granzyme G, CF (10 UG) | 10 UG | R&D SYSTEMS |
| 1357-BR-050 | Recombinant Mouse BAFF R/Fc Chimera, CF (50 UG) | 50 UG | R&D SYSTEMS |
| 1360-GR-050 | Recombinant Mouse Growth Hormone R (GHR)/Fc Chimera, CF (50 UG) | 50 UG | R&D SYSTEMS |
| 1365-SE-010 | Recombinant Mouse Granzyme D, CF (10 UG) | 10 UG | R&D SYSTEMS |
| 1366-PT-050 | Recombinant Human PTP1B (aa 2-321), CF (50 UG) | 50 UG | R&D SYSTEMS |
| 136-AN-050 | Recombinant Mouse Angiopoietin-like 3, CF (50 UG) | 50 UG | R&D SYSTEMS |
| 1375-IL-025 | Recombinant Human IL-26/AK155 Monomer (25 UG) | 25 UG | R&D SYSTEMS |
| 1375-IL-025/CF | Recombinant Human IL-26/AK155 Monomer, CF (25 UG) | 25 UG | R&D SYSTEMS |
| 1377-SE-010 | Recombinant Human Granzyme H, CF (10 UG) | 10 UG | R&D SYSTEMS |
| 1378-RP-050 | Recombinant Mouse RP105/Fc Chimera, CF (50 UG) | 50 UG | R&D SYSTEMS |
| 137-PS-050 | Recombinant Human P-Selectin/CD62P/Fc Chimera, CF (50 UG) | 50 UG | R&D SYSTEMS |
| 1380-UL-050 | Recombinant Human ULBP-1/Fc Chimera, CF (50 UG) | 50 UG | R&D SYSTEMS |
| 1384-SF-025 | Recombinant Human sFRP-1 (25 UG) | 25 UG | R&D SYSTEMS |
| 1384-SF-025/CF | Recombinant Human sFRP-1, CF (25 UG) | 25 UG | R&D SYSTEMS |
| 1385-RT-050 | Recombinant Human RELT/TNFRSF19L/Fc Chimera, CF (50 UG) | 50 UG | R&D SYSTEMS |
| 1388-NC-050 | Recombinant Human N-Cadherin/Fc Chimera, CF (50 UG) | 50 UG | R&D SYSTEMS |
| 1389-D4-050 | Recombinant Mouse DLL4 (50 UG) | 50 UG | R&D SYSTEMS |
| 1389-D4-050/CF | Recombinant Mouse DLL4, CF (50 UG) | 50 UG | R&D SYSTEMS |
| 1390-ER-050 | Recombinant Mouse Erythropoietin R/Fc, Chimera, CF (50 UG) | 50 UG | R&D SYSTEMS |
| 1394-NP-050 | Recombinant Mouse Nope/Fc Chimera, CF (50 UG) | 50 UG | R&D SYSTEMS |
| 1395-KC-025 | Recombinant Mouse KC (aa 29-96) (25 UG) | 25 UG | R&D SYSTEMS |
| 1395-KC-025/CF | Recombinant Mouse KC (aa 29-96), CF (25 UG) | 25 UG | R&D SYSTEMS |
| 1396-KN-050 | Recombinant Human Kininostatin (50 UG) | 50 UG | R&D SYSTEMS |
| 1396-KN-050/CF | Recombinant Human Kininostatin, CF (50 UG) | 50 UG | R&D SYSTEMS |
| 1397-B3-050 | Recombinant Mouse B7-H3 (50 UG) | 50 UG | R&D SYSTEMS |
| 1397-B3-050/CF | Recombinant Mouse B7-H3, CF (50 UG) | 50 UG | R&D SYSTEMS |
| 1398-TS-010 | Recombinant Human TSLP (10 UG) | 10 UG | R&D SYSTEMS |
| 1398-TS-010/CF | Recombinant Human TSLP, CF (10 UG) | 10 UG | R&D SYSTEMS |
| 1399-IL-025 | Recombinant Mouse IL-17E (25 UG) | 25 UG | R&D SYSTEMS |
| 1399-IL-025/CF | Recombinant Mouse IL-17E, CF (25 UG) | 25 UG | R&D SYSTEMS |
| 139-NK-050 | Recombinant Mouse NKG2D/Fc Chimera, CF (50 UG) | 50 UG | R&D SYSTEMS |
| 1400-IR-050 | Recombinant Human IL-23 R/Fc Chimera, CF (50 UG) | 50 UG | R&D SYSTEMS |
| 1404-TC-050 | Recombinant Mouse TrkC (50 UG) | 50 UG | R&D SYSTEMS |
| 1404-TC-050/CF | Recombinant Mouse TrkC, CF (50 UG) | 50 UG | R&D SYSTEMS |
| 1405-UN-050 | Recombinant Rat UNC5H1/Fc Chimera, CF (50 UG) | 50 UG | R&D SYSTEMS |
| 1406-ST-025 | Recombinant Human SOST (25 UG) | 25 UG | R&D SYSTEMS |
| 1406-ST-025/CF | Recombinant Human SOST, CF (25 UG) | 25 UG | R&D SYSTEMS |
| 1407-PI-050 | Recombinant Human Cystatin A, CF (50 UG) | 50 UG | R&D SYSTEMS |
| 1408-PI-050 | Recombinant Human Cystatin B, CF (50 UG) | 50 UG | R&D SYSTEMS |
| 1409-PI-050 | Recombinant Mouse Cystatin B, CF (50 UG) | 50 UG | R&D SYSTEMS |
| 140-B1-100 | Recombinant Human B7-1/CD80/Fc Chimera, CF (100 UG) | 100 UG | R&D SYSTEMS |
| 1410-CR-050 | Recombinant Human Cryptic (50 UG) | 50 UG | R&D SYSTEMS |
| 1410-CR-050/CF | Recombinant Human Cryptic, CF (50 UG) | 50 UG | R&D SYSTEMS |
| 1413-FB-025 | Recombinant Rat FGF-BP (25 UG) | 25 UG | R&D SYSTEMS |
| 1413-FB-025/CF | Recombinant Rat FGF-BP, CF (25 UG) | 25 UG | R&D SYSTEMS |
| 141-B2-100 | Recombinant Human B7-2/CD86/Fc Chimera, CF (100 UG) | 100 UG | R&D SYSTEMS |
| 1429-UN-050 | Recombinant Human UNC5H4/Fc Chimera, CF (50 UG) | 50 UG | R&D SYSTEMS |
| 142-DC-100 | Recombinant Human DcR3/TNFRSF6B/Fc Chimera, CF (100 UG) | 100 UG | R&D SYSTEMS |
| 1433-OP-050 | Recombinant Human Osteopontin (OPN) (50 UG) | 50 UG | R&D SYSTEMS |
| 1433-OP-050/CF | Recombinant Human Osteopontin (OPN), CF (50 UG) | 50 UG | R&D SYSTEMS |
| 1437-CD-050 | Recombinant Mouse CD83/Fc Chimera, CF (50 UG) | 50 UG | R&D SYSTEMS |
| 143-DE-100 | Recombinant Human Decorin, CF (100 UG) | 100 UG | R&D SYSTEMS |
| 1440-NG-050 | Recombinant Mouse Nogo Receptor/Fc Chimera, CF (50 UG) | 50 UG | R&D SYSTEMS |
| 1445-PL-050 | Recombinant Mouse Prolactin (50 UG) | 50 UG | R&D SYSTEMS |
| 1445-PL-050/CF | Recombinant Mouse Prolactin, CF (50 UG) | 50 UG | R&D SYSTEMS |
| 1447-PC-025 | Recombinant Mouse PDGF-CC (25 UG) | 25 UG | R&D SYSTEMS |
| 1447-PC-025/CF | Recombinant Mouse PDGF-CC, CF (25 UG) | 25 UG | R&D SYSTEMS |
| 144-DR-100 | Recombinant Human DR6/TNFRSF21/Fc Chimera, CF (100 UG) | 100 UG | R&D SYSTEMS |
| 1454-ZN-010 | Recombinant Mouse Kell, CF (10 UG) | 10 UG | R&D SYSTEMS |
| 1458-HT-100 | Recombinant Human HTRA2/Omi, CF (100 UG) | 100 UG | R&D SYSTEMS |
| 1459-S4-050 | Recombinant Mouse IGSF4, CF (50 UG) | 50 UG | R&D SYSTEMS |
| 145-CR-010 | Recombinant Human Cripto-1 (10 UG) | 10 UG | R&D SYSTEMS |
| 145-CR-010/CF | Recombinant Human Cripto-1, CF (10 UG) | 10 UG | R&D SYSTEMS |
| 1460-CD-050 | Recombinant Mouse Fc gamma RIIB/CD32b, CF (50 UG) | 50 UG | R&D SYSTEMS |
| 146-IR-100 | Recombinant Human IL-13 R alpha 1/Fc Chimera, CF (100 UG) | 100 UG | R&D SYSTEMS |
| 1470-PI-010 | Recombinant Human Serpin F2/alpha 2-Antiplasmin, CF (10 UG) | 10 UG | R&D SYSTEMS |
| 1473-SE-010 | Recombinant Human Coagulation Factor II/Thrombin, CF (10 UG) | 10 UG | R&D SYSTEMS |
| 1476-TR-050 | Recombinant Mouse TLR1, CF | 50 µg | R&D SYSTEMS |
| 1477-AR-050 | Recombinant Mouse Activin RIB/ALK-4/Fc Chimera, CF | 50 µg | R&D SYSTEMS |
| 1479-TC-050 | Recombinant Human TCCR/WSX-1/Fc Chimera, CF (50 UG) | 50 UG | R&D SYSTEMS |
| 147-IR-100 | Recombinant Human IL-15 R alpha/Fc Chimera, CF (100 UG) | 100 UG | R&D SYSTEMS |
| 1487-TR-050 | Recombinant Human TLR3, CF (50 UG) | 50 UG | R&D SYSTEMS |
| 148-BC-100 | Recombinant Human BCAM/Fc Chimera, CF (100 UG) | 100 UG | R&D SYSTEMS |
| 1493-CD-050 | Recombinant Human CD40/TNFRSF5/Fc Chimera, CF (50 UG) | 50 UG | R&D SYSTEMS |
| 1494-TB-025 | Recombinant Mouse TrkB (25 UG) | 25 UG | R&D SYSTEMS |
| 1494-TB-025/CF | Recombinant Mouse TrkB, CF (25 UG) | 25 UG | R&D SYSTEMS |
| 1503-SE-010 | Recombinant Human Furin, CF (10 UG) | 10 UG | R&D SYSTEMS |
| 1504-IL-025 | Recombinant Human IL-17D (25 UG) | 25 UG | R&D SYSTEMS |
| 1504-IL-025/CF | Recombinant Human IL-17D, CF (25 UG) | 25 UG | R&D SYSTEMS |
| 1505-LR-025 | Recombinant Human LRP-6/Fc Chimera, CF (25 UG) | 25 UG | R&D SYSTEMS |
| 1506-D4-050 | Recombinant Human DLL4 (50 UG) | 50 UG | R&D SYSTEMS |
| 1506-D4-050/CF | Recombinant Human DLL4, CF (50 UG) | 50 UG | R&D SYSTEMS |
| 1507-CT-025 | Recombinant Canine TNF-alpha/TNFSF1A (25 UG) | 25 UG | R&D SYSTEMS |
| 1507-CT-025/CF | Recombinant Canine TNF-alpha/TNFSF2, CF (25 UG) | 25 UG | R&D SYSTEMS |
| 1508-S1-025 | Recombinant Mouse Soggy-1 (25 UG) | 25 UG | R&D SYSTEMS |
| 1508-S1-025/CF | Recombinant Mouse Soggy-1, CF (25 UG) | 25 UG | R&D SYSTEMS |
| 1513-ZN-010 | Recombinant Mouse ACE, CF (10 UG) | 10 UG | R&D SYSTEMS |
| 1514-SE-010 | Recombinant Human HGF Activator, CF (10 UG) | 10 UG | R&D SYSTEMS |
| 1515-CY-010 | Recombinant Mouse Cathepsin L, CF (10 UG) | 10 UG | R&D SYSTEMS |
| 1516-PI-050 | Recombinant Mouse Cystatin/Stefin Homolog 2, CF (50 UG) | 50 UG | R&D SYSTEMS |
| 1517-UL-050 | Recombinant Human ULBP-3/Fc Chimera, CF (50 UG) | 50 UG | R&D SYSTEMS |
| 1525-DC-050 | Recombinant Mouse Dectin-2 alpha, CF (50 UG) | 50 UG | R&D SYSTEMS |
| 1529-TM-050 | Recombinant Mouse TIM-3/Fc Chimera, CF | 50 µg | R&D SYSTEMS |
| 1529-TM-050 | Recombinant Mouse TIM-3/Fc Chimera, CF (50 UG) | 50 UG | R&D SYSTEMS |
| 1530-TR-050 | Recombinant Mouse TLR2, CF (50 UG) | 50 UG | R&D SYSTEMS |
| 1533-TR-050 | Recombinant Mouse TLR6/Fc Chimera, CF (50 UG) | 50 UG | R&D SYSTEMS |
| 1534-LS-050 | Recombinant Rat L-Selectin/CD62L/Fc Chimera, CF (50 UG) | 50 UG | R&D SYSTEMS |
| 1535-LM-010 | Recombinant Mouse Limitin (10 UG) | 10 UG | R&D SYSTEMS |
| 1535-LM-010/CF | Recombinant Mouse Limitin, CF (10 UG) | 10 UG | R&D SYSTEMS |
| 1538-CR-010 | Recombinant Mouse Cripto (10 UG) | 10 UG | R&D SYSTEMS |
| 1538-CR-010/CF | Recombinant Mouse Cripto, CF (10 UG) | 10 UG | R&D SYSTEMS |
| 1539-PG-025 | Recombinant Mouse GDF-8 Propeptide (25 UG) | 25 UG | R&D SYSTEMS |
| 1539-PG-025/CF | Recombinant Mouse GDF-8 Propeptide, CF (25 UG) | 25 UG | R&D SYSTEMS |
| 1543-BP-025 | Recombinant Human BMP-3b/GDF-10 (25 UG) | 25 UG | R&D SYSTEMS |
| 1543-BP-025/CF | Recombinant Human BMP-3b/GDF-10, CF (25 UG) | 25 UG | R&D SYSTEMS |
| 1544-IR-050 | Recombinant Human Insulin R/CD220 (aa 28-956) (50 UG) | 50 UG | R&D SYSTEMS |
| 1544-IR-050/CF | Recombinant Human Insulin R/CD220 (aa 28-956), CF (50 UG) | 50 UG | R&D SYSTEMS |
| 1545-RA-025 | Recombinant Rat IL-1ra/IL-1F3 (25 UG) | 25 UG | R&D SYSTEMS |
| 1545-RA-025/CF | Recombinant Rat IL-1ra/IL-1F3, CF (25 UG) | 25 UG | R&D SYSTEMS |
| 1546-GM-025 | Recombinant Canine GM-CSF (25 UG) | 25 UG | R&D SYSTEMS |
| 1546-GM-025/CF | Recombinant Canine GM-CSF, CF (25 UG) | 25 UG | R&D SYSTEMS |
| 1548-TR-100 | Recombinant Human TROY/TNFRSF19/Fc Chimera, CF (100 UG) | 100 UG | R&D SYSTEMS |
| 1549-S1-025 | Recombinant Human Soggy-1 (25 UG) | 25 UG | R&D SYSTEMS |
| 1549-S1-025/CF | Recombinant Human Soggy-1, CF (25 UG) | 25 UG | R&D SYSTEMS |
| 154-AL-100 | Recombinant Human Axl/Fc Chimera, CF (100 UG) | 100 UG | R&D SYSTEMS |
| 1559-NT-050 | Recombinant Human Notch-3 (aa 40-467)/Fc Chimera, CF (50 UG) | 50 UG | R&D SYSTEMS |
| 1563-PI-050 | Recombinant Mouse Fetuin A/AHSG, CF (50 UG) | 50 UG | R&D SYSTEMS |
| 1564-LX-050 | Recombinant Mouse LOX-1, CF (50 UG) | 50 UG | R&D SYSTEMS |
| 1568-HP-050 | Recombinant Mouse Hip (50 UG) | 50 UG | R&D SYSTEMS |
| 1568-HP-050/CF | Recombinant Mouse Hip, CF (50 UG) | 50 UG | R&D SYSTEMS |
| 1569-PI-010 | Recombinant Human Kininogen HMW (HKa), CF (10 UG) | 10 UG | R&D SYSTEMS |
| 156-B7-100 | Recombinant Human B7-H1/Fc Chimera, CF (100 UG) | 100 UG | R&D SYSTEMS |
| 1577-IL-010 | Recombinant Rhesus Macaque IL-4 (10 UG) | 10 UG | R&D SYSTEMS |
| 1577-IL-010/CF | Recombinant Rhesus Macaque IL-4, CF (10 UG) | 10 UG | R&D SYSTEMS |
| 1578-HC-025 | Recombinant Human CCL14a/HCC-1 (aa 28-93) (25 UG) | 25 UG | R&D SYSTEMS |
| 1578-HC-025/CF | Recombinant Human CCL14a/HCC-1 (aa 28-93), CF (25 UG) | 25 UG | R&D SYSTEMS |
| 157-ER-100 | Recombinant Human EDAR/Fc Chimera, CF (100 UG) | 100 UG | R&D SYSTEMS |
| 1580-HS-050 | Recombinant Human HSP27, CF (50 UG) | 50 UG | R&D SYSTEMS |
| 1585-SE-010 | Recombinant Human Enteropeptidase/Enterokinase, CF (10 UG) | 10 UG | R&D SYSTEMS |
| 1586-HG-025 | Recombinant Equine IFN-gamma (25 UG) | 25 UG | R&D SYSTEMS |
| 1586-HG-025/CF | Recombinant Equine IFN-gamma, CF (25 UG) | 25 UG | R&D SYSTEMS |
| 1587-IL-025 | Recombinant Human IL-28A/IFN-lambda 2 (25 UG) | 25 UG | R&D SYSTEMS |
| 1587-IL-025/CF | Recombinant Human IL-28A/IFN-lambda 2, CF (25 UG) | 25 UG | R&D SYSTEMS |
| 1588-B1-025 | Recombinant Mouse IGFBP-1, CF (25 UG) | 25 UG | R&D SYSTEMS |
| 1589-ST-025 | Recombinant Mouse SOST (25 UG) | 25 UG | R&D SYSTEMS |
| 1589-ST-025/CF | Recombinant Mouse SOST, CF (25 UG) | 25 UG | R&D SYSTEMS |
| 158-B7-100 | Recombinant Mouse B7-H2/Fc Chimera, CF (100 UG) | 100 UG | R&D SYSTEMS |
| 1595-SE-010 | Recombinant Human Kallikrein 11, CF (10 UG) | 10 UG | R&D SYSTEMS |
| 1596-B1-200 | Recombinant Rat EphB1/Fc Chimera, CF (200 UG) | 200 UG | R&D SYSTEMS |
| 1597-FC-050 | Recombinant Human Fc gamma RIIIB/CD16b (50 UG) | 50 UG | R&D SYSTEMS |
| 1597-FC-050/CF | Recombinant Human Fc gamma RIIIB/CD16b, CF (50 UG) | 50 UG | R&D SYSTEMS |
| 1598-IL-025 | Recombinant Human IL-29/IFN-lambda 1 (25 UG) | 25 UG | R&D SYSTEMS |
| 1598-IL-025/CF | Recombinant Human IL-29/IFN-lambda 1, CF (25 UG) | 25 UG | R&D SYSTEMS |
| 1599-MB-050 | Recombinant Human MICB (aa 23-298)/Fc Chimera, CF (50 UG) | 50 UG | R&D SYSTEMS |
| 159-DP-020 | Recombinant Drosophila Decapentaplegic (Dpp) (20 UG) | 20 UG | R&D SYSTEMS |
| 159-DP-020/CF | Recombinant Drosophila Decapentaplegic (Dpp) , CF (20 UG) | 20 UG | R&D SYSTEMS |
| 1600-R2-050 | Recombinant Mouse TGF-beta RII/(mouse) Fc Chimera, CF (50 UG) | 50 UG | R&D SYSTEMS |
| 1603-CV-010 | Recombinant Canine VEGF (10 UG) | 10 UG | R&D SYSTEMS |
| 1603-CV-010/CF | Recombinant Canine VEGF, CF (10 UG) | 10 UG | R&D SYSTEMS |
| 1604-MK-010 | Recombinant Human Active MKK6, CF (10 UG) | 10 UG | R&D SYSTEMS |
| 1605-IL-010 | Recombinant Equine IL-10 (10 UG) | 10 UG | R&D SYSTEMS |
| 1605-IL-010/CF | Recombinant Equine IL-10, CF (10 UG) | 10 UG | R&D SYSTEMS |
| 1607-CD-050 | Recombinant Human CD163, CF | 50 µg | R&D SYSTEMS |
| 1608-CL-025 | Recombinant Canine CXCL8/IL-8 (25 UG) | 25 UG | R&D SYSTEMS |
| 1608-CL-025/CF | Recombinant Canine CXCL8/IL-8, CF (25 UG) | 25 UG | R&D SYSTEMS |
| 1609-CL-025 | Recombinant Canine IL-6 (25 UG) | 25 UG | R&D SYSTEMS |
| 1609-CL-025/CF | Recombinant Canine IL-6, CF (25 UG) | 25 UG | R&D SYSTEMS |
| 1610-TW-050 | Recombinant Mouse TWEAK R/TNFRSF12/Fc Chimera, CF (50 UG) | 50 UG | R&D SYSTEMS |
| 1613-IL-020 | Recombinant Equine IL-2 (Cys 141 Ser) (20 UG) | 20 UG | R&D SYSTEMS |
| 1613-IL-020/CF | Recombinant Equine IL-2 (Cys 141 Ser), CF (20 UG) | 20 UG | R&D SYSTEMS |
| 1614-FL-025 | Recombinant Rat Fas Ligand/TNFSF6 (25 UG) | 25 UG | R&D SYSTEMS |
| 1614-FL-025/CF | Recombinant Rat Fas Ligand/TNFSF6, CF (25 UG) | 25 UG | R&D SYSTEMS |
| 1616-RG-050 | Recombinant Rat RAGE/Fc Chimera, CF (50 UG) | 50 UG | R&D SYSTEMS |
| 1617-FZ-050 | Recombinant Human Frizzled-5/Fc Chimera, CF (50 UG) | 50 UG | R&D SYSTEMS |
| 1618-MR-050 | Recombinant Rat MIS RII/Fc Chimera, CF (50 UG) | 50 UG | R&D SYSTEMS |
| 161-DC-050 | Recombinant Human DC-SIGN/CD209/Fc Chimera, CF (50 UG) | 50 UG | R&D SYSTEMS |
| 1627-WS-050 | Recombinant Human WISP-1/CCN4, CF (50 UG) | 50 UG | R&D SYSTEMS |
| 1628-ZN-020 | Recombinant E. coli Methionine Aminopeptidase/METAP, CF (20 UG) | 20 UG | R&D SYSTEMS |
| 162-D2-050 | Recombinant Human DC-SIGNR/CD299/Fc Chimera, CF (50 UG) | 50 UG | R&D SYSTEMS |
| 1635-T2-050 | Recombinant Human Thrombospondin-2, CF (50 UG) | 50 UG | R&D SYSTEMS |
| 1640-NV-050 | Recombinant Human NOV/CCN3, CF (50 UG) | 50 UG | R&D SYSTEMS |
| 1645-ZN-010 | Recombinant Human ECE-2, CF (10 UG) | 10 UG | R&D SYSTEMS |
| 1647-KR-025 | Recombinant Mouse Kremen-1 (25 UG) | 25 UG | R&D SYSTEMS |
| 1647-KR-025/CF | Recombinant Mouse Kremen-1, CF (25 UG) | 25 UG | R&D SYSTEMS |
| 1648-CB-050 | Recombinant Human CDC25A (aa 336-524), CF (50 UG) | 50 UG | R&D SYSTEMS |
| 1649-CD-050 | Recombinant Human CDC25B (aa 377-566), CF (50 UG) | 50 UG | R&D SYSTEMS |
| 1654-VH-050 | Recombinant Human VHR, CF (50 UG) | 50 UG | R&D SYSTEMS |
| 165-B7-100 | Recombinant Human B7-H2/Fc Chimera, CF (100 UG) | 100 UG | R&D SYSTEMS |
| 1667-SE-010 | Recombinant Human Tryptase gamma-1/TPSG1, CF (10 UG) | 10 UG | R&D SYSTEMS |
| 1668-ZN-020 | Recombinant Human Pappalysin-2/PAPP-A2, CF (20 UG) | 20 UG | R&D SYSTEMS |
| 1669-PI-020 | Recombinant Human Serpin A4/Kallistatin, CF (20 UG) | 20 UG | R&D SYSTEMS |
| 1670-SE-020 | Recombinant E. coli HTRA/Protease Do, CF (20 UG) | 20 UG | R&D SYSTEMS |
| 1673-OM-025 | Recombinant Human OMgp, CF (25 UG) | 25 UG | R&D SYSTEMS |
| 1674-MG-025 | Recombinant Mouse OMgp, CF (25 UG) | 25 UG | R&D SYSTEMS |
| 1680-WS-050 | Recombinant Mouse WISP-1/CCN4, CF (50 UG) | 50 UG | R&D SYSTEMS |
| 1686-MR-050 | Recombinant Mouse IL-23 R/Fc Chimera, CF (50 UG) | 50 UG | R&D SYSTEMS |
| 1687-CC-025 | Recombinant Human PDGF-CC (25 UG) | 25 UG | R&D SYSTEMS |
| 1687-CC-025/CF | Recombinant Human PDGF-CC, CF (25 UG) | 25 UG | R&D SYSTEMS |
| 1688-AC-025 | Recombinant Human gAdiponectin/gAcrp30, CF (25 UG) | 25 UG | R&D SYSTEMS |
| 1689-CD-050 | Recombinant Human CD58/LFA-3 (50 UG) | 50 UG | R&D SYSTEMS |
| 1689-CD-050/CF | Recombinant Human CD58/LFA-3, CF (50 UG) | 50 UG | R&D SYSTEMS |
| 168-CS-100 | Recombinant Mouse ICOS/Fc Chimera, CF (100 UG) | 100 UG | R&D SYSTEMS |
| 1690-HM-025 | Recombinant Human HMGB1, CF (25 UG) | 25 UG | R&D SYSTEMS |
| 1695-CR-050 | Recombinant Human CRTAM/Fc Chimera, CF (50 UG) | 50 UG | R&D SYSTEMS |
| 169-CS-050 | Recombinant Human ICOS/Fc Chimera, CF (50 UG) | 50 UG | R&D SYSTEMS |
| 1705-HH-025 | Recombinant Mouse Indian Hedgehog (C28II) N-Terminus (25 UG) | 25 UG | R&D SYSTEMS |
| 1705-HH-025/CF | Recombinant Mouse Indian Hedgehog (C28II) N-Terminus, CF (25 UG) | 25 UG | R&D SYSTEMS |
| 1706-SF-050 | Recombinant Mouse Siglec-F/Fc Chimera, CF (50 UG) | 50 UG | R&D SYSTEMS |
| 1707-CR-200 | Recombinant Human C-Reactive Protein (200 UG) | 200 UG | R&D SYSTEMS |
| 1707-CR-200/CF | Recombinant Human C-Reactive Protein, CF (200 UG) | 200 UG | R&D SYSTEMS |
| 1708-PI-050 | Recombinant Human Lipocalin-1, CF (50 UG) | 50 UG | R&D SYSTEMS |
| 1709-ML-025 | Recombinant Mouse IL-17B (25 UG) | 25 UG | R&D SYSTEMS |
| 1709-ML-025/CF | Recombinant Mouse IL-17B, CF (25 UG) | 25 UG | R&D SYSTEMS |
| 1710-PI-050 | Recombinant Mouse Cystatin/Stefin Homolog, CF (50 UG) | 50 UG | R&D SYSTEMS |
| 1714-CN-025 | Recombinant Human Contactin-2/TAG1, CF (25 UG) | 25 UG | R&D SYSTEMS |
| 1719-SE-010 | Recombinant Human Kallikrein 4/Prostase, CF (10 UG) | 10 UG | R&D SYSTEMS |
| 1720-DM-50 | Recombinant Human Desmoglein-3/Fc Chimera, CF | 50 µg | R&D SYSTEMS |
| 1724-SE-020 | Recombinant Human Complement MASP3 Catalytic Domain, CF (20 UG) | 20 UG | R&D SYSTEMS |
| 1725-PI-050 | Recombinant Human Fetuin B, CF | 50 µg | R&D SYSTEMS |
| 1729-T2-050 | Recombinant Mouse TREM-2b/Fc Chimera, CF (50 UG) | 50 UG | R&D SYSTEMS |
| 1737-MS-010 | Recombinant Human MIS/AMH (10 UG) | 10 UG | R&D SYSTEMS |
| 1737-MS-010/CF | Recombinant Human MIS/AMH, CF (10 UG) | 10 UG | R&D SYSTEMS |
| 1744-CR-200 | Recombinant Rat C-Reactive Protein (200 UG) | 200 UG | R&D SYSTEMS |
| 1744-CR-200/CF | Recombinant Rat C-Reactive Protein, CF (200 UG) | 200 UG | R&D SYSTEMS |
| 1747-PI-010 | Recombinant Human Trappin-2/Elafin, CF (10 UG) | 10 UG | R&D SYSTEMS |
| 1749-RB-050 | Recombinant Rat ROBO1/Fc Chimera, CF (50 UG) | 50 UG | R&D SYSTEMS |
| 174-TC-050 | Recombinant Human TACI/TNFRSF13B/Fc Chimera, CF (50 UG) | 50 UG | R&D SYSTEMS |
| 1750-TM-050 | Recombinant Human TIM-1/KIM-1/HAVCR, CF (50 UG) | 50 UG | R&D SYSTEMS |
| 1756-DC-050 | Recombinant Mouse Dectin-1/CLEC7A, CF | 50 µg | R&D SYSTEMS |
| 1756-DC-050 | Recombinant Mouse Dectin-1/CLEC7A, CF (50 UG) | 50 UG | R&D SYSTEMS |
| 1757-LC-050 | Recombinant Human Lipocalin-2/NGAL, CF (50 UG) | 50 UG | R&D SYSTEMS |
| 175-TK-050 | Recombinant Human TrkA/Fc Chimera, CF (50 UG) | 50 UG | R&D SYSTEMS |
| 1760-RL-010 | Recombinant Rat IL-12 (10 UG) | 10 UG | R&D SYSTEMS |
| 1760-RL-010/CF | Recombinant Rat IL-12, CF (10 UG) | 10 UG | R&D SYSTEMS |
| 1764-KR-025 | Recombinant Mouse Kremen-2 (25 UG) | 25 UG | R&D SYSTEMS |
| 1764-KR-025/CF | Recombinant Mouse Kremen-2, CF (25 UG) | 25 UG | R&D SYSTEMS |
| 1765-DK-010 | Recombinant Mouse Dkk-1 (10 UG) | 10 UG | R&D SYSTEMS |
| 1765-DK-010/CF | Recombinant Mouse Dkk-1, CF (10 UG) | 10 UG | R&D SYSTEMS |
| 176-GB-025 | Recombinant Human CXCL2/GRO beta (aa 39 – 107) (25 UG) | 25 UG | R&D SYSTEMS |
| 176-GB-025/CF | Recombinant Human CXCL2/GRO beta (aa 39 – 107), CF (25 UG) | 25 UG | R&D SYSTEMS |
| 1774-MC-025 | Recombinant Canine CCL2/MCP-1 (25 UG) | 25 UG | R&D SYSTEMS |
| 1774-MC-025/CF | Recombinant Canine CCL2/MCP-1, CF (25 UG) | 25 UG | R&D SYSTEMS |
| 177-IR-100 | Recombinant Human IL-17 R/Fc Chimera, CF (100 UG) | 100 UG | R&D SYSTEMS |
| 1784-ZN-010 | Recombinant Human ECE-1, CF (10 UG) | 10 UG | R&D SYSTEMS |
| 1785-MP-010 | Recombinant Human MMP-16/MT3-MMP, CF (10 UG) | 10 UG | R&D SYSTEMS |
| 1786-PI-010 | Recombinant Human Serpin E1/PAI-1, CF (10 UG) | 10 UG | R&D SYSTEMS |
| 1787-MD-050 | Recombinant Human MD-2 (50 UG) | 50 UG | R&D SYSTEMS |
| 1787-MD-050/CF | Recombinant Human MD-2, CF (50 UG) | 50 UG | R&D SYSTEMS |
| 1788-IR-050 | Recombinant Human IL-20 R beta/Fc Chimera, CF (50 UG) | 50 UG | R&D SYSTEMS |
| 1789-ML-025 | Recombinant Mouse IL-28B/IFN-lambda 3 (25 UG) | 25 UG | R&D SYSTEMS |
| 1789-ML-025/CF | Recombinant Mouse IL-28B/IFN-lambda 3, CF (25 UG) | 25 UG | R&D SYSTEMS |
| 1790-CA-050 | Recombinant Human Cadherin-11 (CAD-11)/Fc Chimera, CF (50 UG) | 50 UG | R&D SYSTEMS |
| 1794-LT-025 | Recombinant Mouse LIGHT/TNFSF14 (25 UG) | 25 UG | R&D SYSTEMS |
| 1794-LT-025/CF | Recombinant Mouse LIGHT/TNFSF14, CF (25 UG) | 25 UG | R&D SYSTEMS |
| 1795-FL-010 | Recombinant Feline IL-5 (10 UG) | 10 UG | R&D SYSTEMS |
| 1795-FL-010/CF | Recombinant Feline IL-5, CF (10 UG) | 10 UG | R&D SYSTEMS |
| 1796-FL-010 | Recombinant Feline IL-1 beta/IL-1F2 (10 UG) | 10 UG | R&D SYSTEMS |
| 1796-FL-010/CF | Recombinant Feline IL-1 beta/IL-1F2, CF (10 UG) | 10 UG | R&D SYSTEMS |
| 1797-MS-050 | Recombinant Mouse SR-AI/MSR1, CF (50 UG) | 50 UG | R&D SYSTEMS |
| 1798-LX-050 | Recombinant Human LOX-1, CF (50 UG) | 50 UG | R&D SYSTEMS |
| 1806-P3-010 | Recombinant Human Active p38 alpha, CF (10 UG) | 10 UG | R&D SYSTEMS |
| 1807-SE-010 | Recombinant Human Complement Component C1r, CF (10 UG) | 10 UG | R&D SYSTEMS |
| 1808-NR-050 | Recombinant Human Chordin-Like 1 (50 UG) | 50 UG | R&D SYSTEMS |
| 1808-NR-050/CF | Recombinant Human Chordin-Like 1, CF (50 UG) | 50 UG | R&D SYSTEMS |
| 1809-EL-020 | Recombinant Equine IL-4 (20 UG) | 20 UG | R&D SYSTEMS |
| 1809-EL-020/CF | Recombinant Equine IL-4, CF (20 UG) | 20 UG | R&D SYSTEMS |
| 1810-EC-050 | Recombinant Human Endocan (50 UG) | 50 UG | R&D SYSTEMS |
| 1810-EC-050/CF | Recombinant Human Endocan, CF (50 UG) | 50 UG | R&D SYSTEMS |
| 1814-ET-025 | Recombinant Equine TNF-alpha/TNFSF1A (25 UG) | 25 UG | R&D SYSTEMS |
| 1814-ET-025/CF | Recombinant Equine TNF-alpha/TNFSF1A, CF (25 UG) | 25 UG | R&D SYSTEMS |
| 1815-CL-020 | Recombinant Canine IL-2 (20 UG) | 20 UG | R&D SYSTEMS |
| 1815-CL-020/CF | Recombinant Canine IL-2, CF (20 UG) | 20 UG | R&D SYSTEMS |
| 1816-DT-050 | Recombinant Mouse DcTRAIL R2/TNFRSF22 (50 UG) | 50 UG | R&D SYSTEMS |
| 1816-DT-050/CF | Recombinant Mouse DcTRAIL R2/TNFRSF22, CF (50 UG) | 50 UG | R&D SYSTEMS |
| 1817-TM-050 | Recombinant Mouse TIM-1/KIM-1/HAVCR (50 UG) | 50 UG | R&D SYSTEMS |
| 1817-TM-050/CF | Recombinant Mouse TIM-1/KIM-1/HAVCR, CF (50 UG) | 50 UG | R&D SYSTEMS |
| 1819-KL-050 | Recombinant Mouse Klotho (aa 35-982), CF | 50 µg | R&D SYSTEMS |
| 1824-SE-010 | Recombinant Human Complement Factor D, CF (10 UG) | 10 UG | R&D SYSTEMS |
| 1826-TS-025 | Recombinant Human Pentraxin 3/TSG-14 (25 UG) | 25 UG | R&D SYSTEMS |
| 1826-TS-025/CF | Recombinant Human Pentraxin 3/TSG-14, CF (25 UG) | 25 UG | R&D SYSTEMS |
| 1827-SF-025 | Recombinant Human sFRP-4 (25 UG) | 25 UG | R&D SYSTEMS |
| 1827-SF-025/CF | Recombinant Human sFRP-4, CF (25 UG) | 25 UG | R&D SYSTEMS |
| 1829-CR-200 | Recombinant Mouse C-Reactive Protein, CF (200 UG) | 200 UG | R&D SYSTEMS |
| 1830-SR-025 | Recombinant Mouse IL-6 R (aa 20-357) (25 UG) | 25 UG | R&D SYSTEMS |
| 1830-SR-025/CF | Recombinant Mouse IL-6 R (aa 20-357), CF (25 UG) | 25 UG | R&D SYSTEMS |
| 1836-SR-050 | Recombinant Mouse SIGNR1/CD209b/Fc Chimera, CF (50 UG) | 50 UG | R&D SYSTEMS |
| 1845-SH-025 | Recombinant Human Sonic Hedgehog (C24II) N-Terminus (25 UG) | 25 UG | R&D SYSTEMS |
| 1845-SH-025/CF | Recombinant Human Sonic Hedgehog (C24II) N-Terminus, CF (25 UG) | 25 UG | R&D SYSTEMS |
| 1849-NK-025 | Recombinant Human NKp30/Fc Chimera, CF (25 UG) | 25 UG | R&D SYSTEMS |
| 1850-NK-025 | Recombinant Human NKp46/NCR1/Fc Chimera, CF (25 UG) | 25 UG | R&D SYSTEMS |
| 1855-CD-050 | Recombinant Human CD84/SLAMF5 (50 UG) | 50 UG | R&D SYSTEMS |
| 1855-CD-050/CF | Recombinant Human CD84/SLAMF5, CF (50 UG) | 50 UG | R&D SYSTEMS |
| 1857-LC-050 | Recombinant Mouse Lipocalin-2/NGAL, CF (50 UG) | 50 UG | R&D SYSTEMS |
| 1859-DC-050 | Recombinant Human Dectin-1/CLEC7A,CF (50 UG) | 50 UG | R&D SYSTEMS |
| 185-OS-025 | Recombinant Human Osteoprotegerin/TNFRSF11B (25 UG) | 25 UG | R&D SYSTEMS |
| 185-OS-025/CF | Recombinant Human Osteoprotegerin/TNFRSF11B, CF (25 UG) | 25 UG | R&D SYSTEMS |
| 1865-SE-010 | Recombinant Mouse Granzyme B, CF (10 UG) | 10 UG | R&D SYSTEMS |
| 1869-HP-025 | Recombinant Human HPRG, CF (25 UG) | 25 UG | R&D SYSTEMS |
| 1870-IL-010 | Recombinant Human IL-26/AK155 Dimer (10 UG) | 10 UG | R&D SYSTEMS |
| 1870-IL-010/CF | Recombinant Human IL-26/AK155 Dimer, CF (10 UG) | 10 UG | R&D SYSTEMS |
| 1875-CD-050 | Recombinant Human FC gamma RIIB/C (CD32b/c), CF (50 UG) | 50 UG | R&D SYSTEMS |
| 1878-SH-010 | Recombinant Human Active SHP-1 (aa 205-595), CF | 10 µg | R&D SYSTEMS |
| 1886-EL-025 | Recombinant Equine IL-6 (25 UG) | 25 UG | R&D SYSTEMS |
| 1886-EL-025/CF | Recombinant Equine IL-6, CF (25 UG) | 25 UG | R&D SYSTEMS |
| 1887-ML-010 | Recombinant Mouse IL-23 (10 UG) | 10 UG | R&D SYSTEMS |
| 1887-ML-010/CF | Recombinant Mouse IL-23, CF (10 UG) | 10 UG | R&D SYSTEMS |
| 1888-LM-050 | Recombinant Mouse LIMPII/SR-B2/Fc Chimera, CF (50 UG) | 50 UG | R&D SYSTEMS |
| 1889-PI-010 | Recombinant Human Cystatin F, CF (10 UG) | 10 UG | R&D SYSTEMS |
| 188-C8-005 | Recombinant Human Cadherin-8 (CAD-8)/Fc Chimera, CF (5 UG) | 5 UG | R&D SYSTEMS |
| 1890-FL-020 | Recombinant Feline IL-2 (20 UG) | 20 UG | R&D SYSTEMS |
| 1890-FL-020/CF | Recombinant Feline IL-2, CF (20 UG) | 20 UG | R&D SYSTEMS |
| 1894-SH-100 | Recombinant Human Active SHP-2, CF | 100 µg | R&D SYSTEMS |
| 1894-SH-100 | Recombinant Human Active SHP-2, CF | 100 µg | R&D SYSTEMS |
| 1895-SA-050 | Recombinant Rat Pentraxin 2/SAP (50 UG) | 50 UG | R&D SYSTEMS |
| 1895-SA-050/CF | Recombinant Rat Pentraxin 2/SAP, CF (50 UG) | 50 UG | R&D SYSTEMS |
| 1896-TL-010 | Recombinant Mouse TL1A/TNFSF15 (10 UG) | 10 UG | R&D SYSTEMS |
| 1896-TL-010/CF | Recombinant Mouse TL1A/TNFSF15, CF (10 UG) | 10 UG | R&D SYSTEMS |
| 1898-CD-050 | Recombinant Human CD229/SLAMF3, CF | 50 µg | R&D SYSTEMS |
| 1905-HP-025 | Recombinant Mouse HPRG, CF (25 UG) | 25 UG | R&D SYSTEMS |
| 1907-BL-050 | Recombinant Human BLAME/SLAMF8, CF | 50 µg | R&D SYSTEMS |
| 1907-BL-050 | Recombinant Human BLAME/SLAMF8, CF | 50 µg | R&D SYSTEMS |
| 1908-NT-050 | Recombinant Human NTB-A/SLAMF6/Fc Chimera, CF | 50 µg | R&D SYSTEMS |
| 1915-MF-050 | Recombinant Human MFRP, CF (50 UG) | 50 UG | R&D SYSTEMS |
| 1918-FN-02M | Human Fibronectin, CF (2 MG) | 2 MG | R&D SYSTEMS |
| 191-ED-010 | Recombinant Mouse Ectodysplasin (EDA) (10 UG) | 10 UG | R&D SYSTEMS |
| 191-ED-010/CF | Recombinant Mouse Ectodysplasin (Eda), CF (10 UG) | 10 UG | R&D SYSTEMS |
| 1920-SP-050 | Recombinant Human SP-D, CF | 50 µg | R&D SYSTEMS |
| 1920-SP-050 | Recombinant Human SP-D, CF | 50 µg | R&D SYSTEMS |
| 1927-ZN-010 | Recombinant Human BMP-1/PCP, CF (10 UG) | 10 UG | R&D SYSTEMS |
| 1928-SE-010 | Recombinant Mouse Spinesin, CF (10 UG) | 10 UG | R&D SYSTEMS |
| 192-SF-010 | Recombinant Human sFRP-3 (10 UG) | 10 UG | R&D SYSTEMS |
| 192-SF-010/CF | Recombinant Human sFRP-3, CF (10 UG) | 10 UG | R&D SYSTEMS |
| 1930-PT-050 | Recombinant Human TC-PTP (aa 2-314), CF (50 UG) | 50 UG | R&D SYSTEMS |
| 1934-DP-010 | Recombinant Human DEP-1/CD148 (aa 997-1337), CF (10 UG) | 10 UG | R&D SYSTEMS |
| 1936-SE-010 | Recombinant Human Complement Component C2, CF (10 UG) | 10 UG | R&D SYSTEMS |
| 1937-SE-010 | Recombinant Mouse Tryptase beta-1/MCPT-7, CF (10 UG) | 10 UG | R&D SYSTEMS |
| 1938-PI-050 | Human alpha-2-Macroglobulin, CF (50 UG) | 50 UG | R&D SYSTEMS |
| 1939-SE-200 | Human Plasminogen, CF (200 UG) | 200 UG | R&D SYSTEMS |
| 193-BC-050 | Recombinant Human BCMA/TNFRSF17/Fc Chimera, CF (50 UG) | 50 UG | R&D SYSTEMS |
| 1945-RL-025 | Recombinant Rat IL-13 (25 UG) | 25 UG | R&D SYSTEMS |
| 1945-RL-025/CF | Recombinant Rat IL-13, CF (25 UG) | 25 UG | R&D SYSTEMS |
| 1946-KR-025 | Recombinant Human Kremen-2 (25 UG) | 25 UG | R&D SYSTEMS |
| 1946-KR-025/CF | Recombinant Human Kremen-2, CF (25 UG) | 25 UG | R&D SYSTEMS |
| 1947-MS-050 | Recombinant Human MSP R/Ron, CF (50 UG) | 50 UG | R&D SYSTEMS |
| 1948-SA-050 | Recombinant Human Pentraxin 2/SAP (50 UG) | 50 UG | R&D SYSTEMS |
| 1948-SA-050/CF | Recombinant Human Pentraxin 2/SAP, CF (50 UG) | 50 UG | R&D SYSTEMS |
| 1949-B3-050 | Recombinant Human B7-H3 (50 UG) | 50 UG | R&D SYSTEMS |
| 1949-B3-050/CF | Recombinant Human B7-H3, CF (50 UG) | 50 UG | R&D SYSTEMS |
| 194-FZ-050 | Recombinant Mouse Frizzled-4/Fc Chimera, CF (50 UG) | 50 UG | R&D SYSTEMS |
| 1950-M5-050 | Recombinant Human ICAM-5/Fc Chimera, CF (50 UG) | 50 UG | R&D SYSTEMS |
| 1954-FL-025 | Recombinant Feline IL-12 (25 UG) | 25 UG | R&D SYSTEMS |
| 1954-FL-025/CF | Recombinant Feline IL-12, CF (25 UG) | 25 UG | R&D SYSTEMS |
| 1955-CD-050 | Recombinant Human CD36/SR-B3/Fc Chimera, CF (50 UG) | 50 UG | R&D SYSTEMS |
| 1956-CV-050 | Recombinant Human Crossveinless-2 (50 UG) | 50 UG | R&D SYSTEMS |
| 1956-CV-050/CF | Recombinant Human Crossveinless-2, CF (50 UG) | 50 UG | R&D SYSTEMS |
| 1957-KG-025 | Recombinant Canine KGF/FGF-7 (25 UG) | 25 UG | R&D SYSTEMS |
| 1957-KG-025/CF | Recombinant Canine KGF/FGF-7, CF (25 UG) | 25 UG | R&D SYSTEMS |
| 1958-GD-010 | Recombinant Human GDF-11/BMP-11 (10 UG) | 10 UG | R&D SYSTEMS |
| 1958-GD-010/CF | Recombinant Human GDF-11/BMP-11, CF (10 UG) | 10 UG | R&D SYSTEMS |
| 1959-B2-050 | Recombinant Human IL-12 R beta 2/Fc Chimera, CF (50 UG) | 50 UG | R&D SYSTEMS |
| 1960-FC-050 | Recombinant Mouse Fc gamma RIII/CD16, CF (50 UG) | 50 UG | R&D SYSTEMS |
| 1964-CL-025 | Recombinant Canine IL-5 (25 UG) | 25 UG | R&D SYSTEMS |
| 1964-CL-025/CF | Recombinant Canine IL-5, CF (25 UG) | 25 UG | R&D SYSTEMS |
| 1965-IL-025 | Recombinant Human IL-24 (25 UG) | 25 UG | R&D SYSTEMS |
| 1965-IL-025/CF | Recombinant Human IL-24, CF (25 UG) | 25 UG | R&D SYSTEMS |
| 1966-LM-050 | Recombinant Human LIMPII/SR-B2/Fc Chimera, CF (50 UG) | 50 UG | R&D SYSTEMS |
| 1967-NG-025/CF | Recombinant Mouse Noggin, CF (25 UG) | 25 UG | R&D SYSTEMS |
| 1968-SL-050 | Recombinant Human Siglec-2/CD22/Fc Chimera, CF (50 UG) | 50 UG | R&D SYSTEMS |
| 1969-CL-025 | Recombinant Canine IL-12/IL-23 p40 (25 UG) | 25 UG | R&D SYSTEMS |
| 1969-CL-025/CF | Recombinant Canine IL-12/IL-23 p40, CF (25 UG) | 25 UG | R&D SYSTEMS |
| 1970-TX-500 | Recombinant Human Thioredoxin-1, CF (500 UG) | 500 UG | R&D SYSTEMS |
| 1974-CD-050 | Recombinant Mouse Fcrl3/CD16-2, CF (50 UG) | 50 UG | R&D SYSTEMS |
| 1975-IL-025 | Recombinant Human IL-1F7/FIL1 zeta, CF (25 UG) | 25 UG | R&D SYSTEMS |
| 1976-NV-050 | Recombinant Mouse NOV/CCN3, CF (50 UG) | 50 UG | R&D SYSTEMS |
| 1977-MR-050 | Recombinant Human IL-11 R alpha/Fc Chimera, CF (50 UG) | 50 UG | R&D SYSTEMS |
| 1978-MF-025 | Recombinant Mouse MIF (25 UG) | 25 UG | R&D SYSTEMS |
| 1978-MF-025/CF | Recombinant Mouse MIF, CF (25 UG) | 25 UG | R&D SYSTEMS |
| 1988-SE-010 | Recombinant Human Marapsin/Pancreasin, CF (10 UG) | 10 UG | R&D SYSTEMS |
| 1989-SE-010 | Recombinant Mouse Marapsin/Pancreasin, CF (10 UG) | 10 UG | R&D SYSTEMS |
| 198-FZ-050 | Recombinant Mouse Frizzled-7/Fc Chimera, CF (50 UG) | 50 UG | R&D SYSTEMS |
| 1998-B1-050 | Recombinant Mouse IL-12 R beta 1, CF (50 UG) | 50 UG | R&D SYSTEMS |
| 1999-EC-050 | Recombinant Mouse Endocan, CF | 50 µg | R&D SYSTEMS |
| 2009-CD-050 | Recombinant Human CD55/DAF (50 UG) | 50 UG | R&D SYSTEMS |
| 2009-CD-050/CF | Recombinant Human CD55/DAF, CF (50 UG) | 50 UG | R&D SYSTEMS |
| 200-LA-002 | Recombinant Human IL-1 alpha/IL-1F1 (2 UG) | 2 UG | R&D SYSTEMS |
| 200-LA-002/CF | Recombinant Human IL-1 alpha/IL-1F1, CF (2 UG) | 2 UG | R&D SYSTEMS |
| 200-LA-010 | Recombinant Human IL-1 alpha/IL-1F1 (10 UG) | 10 UG | R&D SYSTEMS |
| 200-LA-010/CF | Recombinant Human IL-1 alpha/IL-1F1, CF (10 UG) | 10 UG | R&D SYSTEMS |
| 2017-T2-050 | Recombinant Human ILT2/CD85/Fc Chimera, CF (50 UG) | 50 UG | R&D SYSTEMS |
| 201-LB-005 | Recombinant Human IL-1 beta/IL-1F2 (5 UG) | 5 UG | R&D SYSTEMS |
| 201-LB-005/CF | Recombinant Human IL-1 beta/IL-1F2, CF (5 UG) | 5 UG | R&D SYSTEMS |
| 201-LB-025 | Recombinant Human IL-1 beta/IL-1F2 (25 UG) | 25 UG | R&D SYSTEMS |
| 201-LB-025/CF | Recombinant Human IL-1 beta/IL-1F2, CF (25 UG) | 25 UG | R&D SYSTEMS |
| 2025-SE-010 | Recombinant Human Kallikrein 8/Neuropsin, CF (10 UG) | 10 UG | R&D SYSTEMS |
| 2026-EM-050 | Recombinant Mouse Pro-EMAP-II, CF | 50 µg | R&D SYSTEMS |
| 2026-EM-050 | Recombinant Mouse Pro-EMAP-II, CF | 50 µg | R&D SYSTEMS |
| 2028-EG-200 | Recombinant Mouse EGF, CF (200 UG) | 200 UG | R&D SYSTEMS |
| 202-IL-010/CF | Recombinant Human IL-2, CF (10 UG) | 10 UG | R&D SYSTEMS |
| 202-IL-050/CF | Recombinant Human IL-2, CF (50 UG) | 50 UG | R&D SYSTEMS |
| 2034-NR-050 | Recombinant Human NrCAM/Fc Chimera, CF (50 UG) | 50 UG | R&D SYSTEMS |
| 2036-BC-050 | Recombinant Human BOC, CF | 50 µg | R&D SYSTEMS |
| 2037-C5-025 | Recombinant Human Complement Component C5a (25 UG) | 25 UG | R&D SYSTEMS |